Biomarin Pharmaceutical Inc (BMRN)
Operating profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 158,097 | 149,562 | -82,341 | -43,440 | -100,457 |
| Revenue | US$ in thousands | 2,374,190 | 2,068,670 | 1,832,750 | 1,823,140 | 1,680,280 |
| Operating profit margin | 6.66% | 7.23% | -4.49% | -2.38% | -5.98% |
December 31, 2023 calculation
Operating profit margin = Operating income ÷ Revenue
= $158,097K ÷ $2,374,190K
= 6.66%
The operating profit margin of Biomarin Pharmaceutical Inc has fluctuated over the past five years. In 2023, the operating profit margin stood at 6.66%, which was a slight decrease from 7.23% in 2022. Despite the decrease, the company still maintained a positive operating profit margin, indicating efficiency in managing operating expenses relative to revenue.
In contrast, Biomarin Pharmaceutical Inc incurred negative operating profit margins in the years 2021, 2020, and 2019, with figures of -4.49%, -2.38%, and -5.98% respectively. These negative margins suggest that the company's operating expenses exceeded its operating income during those years, indicating potential challenges in cost management and generating profitability from core operations.
Overall, Biomarin Pharmaceutical Inc's operating profit margin performance has shown variability in recent years, with 2023 reflecting a slight decline but maintaining a positive margin. However, the company has had periods of negative operating profit margins in the past, highlighting the importance of consistently monitoring and managing operational efficiency and cost controls.
Peer comparison
Dec 31, 2023